Clinical trials
Neoplasms trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
126 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 8 |
| 2012 | 7 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 75 |
| Recruiting | 19 |
| Active, not recruiting | 14 |
| Terminated | 9 |
| Unknown status | 7 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 19 |
| Norwegian University of Science and Technology | 13 |
| AstraZeneca | 7 |
| Haukeland University Hospital | 5 |
| Novartis Pharmaceuticals | 5 |
| AbbVie | 4 |
| GlaxoSmithKline | 4 |
| Sykehuset Innlandet HF | 4 |
| Clavis Pharma | 3 |
| Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 126 |
| Breast Neoplasms | 10 |
| Melanoma | 8 |
| Neoplasm Metastasis | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Neoplasms by Site | 7 |
| Pain | 6 |
| Recurrence | 6 |
| Adenocarcinoma | 5 |
| Carcinoma | 5 |
Trials
Showing 1 to 25 of 126. Each trial links to its page on Pharma Observatory.
26 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.